Wolf, Greenfield & Sacks, P.C.
Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
The invention pertains to the generation and utility of antibodies that can bind effectively to CεmX domain on membrane-bound IgE (mIgE) expressed on the surface of human B lymphocytes. The CεmX domain of 52 amino acid residues, located between the CH4 domain and the C-terminal membrane-anchor peptide on human membrane-bound epsilon chain, had been suggested as an antigenic site for immunological targeting of B cells expressing mIgE. Previous reported monoclonal antibodies, including a20, which bind to RADWPGPP (SEQ ID NO:1) peptide at the C-terminal of CεmX, have now been found to bind poorly to mIgE on human B cells. We have discovered that only monoclonal antibodies specific for certain segments, such as GLAGGSAQSQRAPDRVL (SEQ ID NO:2) and HSGQQQGLPRAAGGSVPHPR (SEQ ID NO:3), of CεmX can bind effectively to mIgE on human B cells and hence have the utility for targeting those B cells for the treatment of diseases mediated by IgE.
Academia Sinica
C C A C A A A A Y C Y A A Y Y A C A C C A A A C A C
C07K C07K A61P C07K A61P A61P A61P A61P Y10S C07K Y10S A61P A61P Y10S Y10S A61P C07K A61P C07K C07K A61P A61P A61P C07K A61K C07K
additional additional inventional additional inventional inventional inventional inventional additional additional additional inventional inventional additional additional inventional additional inventional inventional additional inventional inventional inventional additional inventional inventional
Alfur F. Pheidias C. Jiun-Bo Tsewen
Hung Wu Chen Chang